Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9308571 | Kidney International | 2005 | 6 Pages |
Abstract
In ESRD patients, folic acid treatment lowers, but does not normalize plasma homocysteine, whereas homocysteine remethylation and methionine transmethylation increase to levels found in untreated healthy controls. These findings indicate a persistent, folate-independent, defect in metabolic homocysteine clearance in ESRD.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Frank Stam, Coen Van Guldener, Piet M. Ter Wee, Cornelis Jakobs, Kees De Meer, Coen D.A. M.D.,